These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
184 related items for PubMed ID: 27098748
1. Genetic findings in treatment-naïve and proton-beam-radiated iris melanomas. Krishna Y, Kalirai H, Thornton S, Damato BE, Heimann H, Coupland SE. Br J Ophthalmol; 2016 Jul; 100(7):1012-1016. PubMed ID: 27098748 [Abstract] [Full Text] [Related]
2. Concordant chromosome 3 results in paired choroidal melanoma biopsies and subsequent tumour resection specimens. Coupland SE, Kalirai H, Ho V, Thornton S, Damato BE, Heimann H. Br J Ophthalmol; 2015 Oct; 99(10):1444-50. PubMed ID: 26206786 [Abstract] [Full Text] [Related]
3. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma. Staby KM, Gravdal K, Mørk SJ, Heegaard S, Vintermyr OK, Krohn J. Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874 [Abstract] [Full Text] [Related]
4. Effects of plaque brachytherapy and proton beam radiotherapy on prognostic testing: a comparison of uveal melanoma genotyped by microsatellite analysis. Thornton S, Coupland SE, Heimann H, Hussain R, Groenewald C, Kacperek A, Damato B, Taktak A, Eleuteri A, Kalirai H. Br J Ophthalmol; 2020 Oct; 104(10):1462-1466. PubMed ID: 32024655 [Abstract] [Full Text] [Related]
5. The T1799A BRAF mutation is present in iris melanoma. Henriquez F, Janssen C, Kemp EG, Roberts F. Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):4897-900. PubMed ID: 17962436 [Abstract] [Full Text] [Related]
6. Conservative management of suspicious melanocytic lesions of the iris. Oxenreiter MM, Lane AM, Jain P, Kim IK, Gragoudas ES. Graefes Arch Clin Exp Ophthalmol; 2019 Jun; 257(6):1319-1324. PubMed ID: 30919077 [Abstract] [Full Text] [Related]
7. Genetic Background of Iris Melanomas and Iris Melanocytic Tumors of Uncertain Malignant Potential. van Poppelen NM, Vaarwater J, Mudhar HS, Sisley K, Rennie IG, Rundle P, Brands T, van den Bosch QCC, Mensink HW, de Klein A, Kiliç E, Verdijk RM. Ophthalmology; 2018 Jun; 125(6):904-912. PubMed ID: 29371009 [Abstract] [Full Text] [Related]
8. Comparison of formalin-fixed and snap-frozen samples analyzed by multiplex ligation-dependent probe amplification for prognostic testing in uveal melanoma. Lake SL, Kalirai H, Dopierala J, Damato BE, Coupland SE. Invest Ophthalmol Vis Sci; 2012 May 04; 53(6):2647-52. PubMed ID: 22427594 [Abstract] [Full Text] [Related]
9. MicroRNA expression analysis and Multiplex ligation-dependent probe amplification in metastatic and non-metastatic uveal melanoma. Larsen AC, Holst L, Kaczkowski B, Andersen MT, Manfé V, Siersma VD, Kolko M, Kiilgaard JF, Winther O, Prause JU, Gniadecki R, Heegaard S. Acta Ophthalmol; 2014 Sep 04; 92(6):541-9. PubMed ID: 24373459 [Abstract] [Full Text] [Related]
10. Chromosomal aberrations in iris melanomas. Mensink HW, Vaarwater J, de Keizer RJ, de Wolff-Rouendaal D, Mooy CM, de Klein A, Paridaens D. Br J Ophthalmol; 2011 Mar 04; 95(3):424-8. PubMed ID: 20881029 [Abstract] [Full Text] [Related]
11. Prognostic biopsy of choroidal melanoma: an optimised surgical and laboratory approach. Angi M, Kalirai H, Taktak A, Hussain R, Groenewald C, Damato BE, Heimann H, Coupland SE. Br J Ophthalmol; 2017 Aug 04; 101(8):1143-1146. PubMed ID: 28596284 [Abstract] [Full Text] [Related]
12. Multiplex ligation-dependent probe amplification equals fluorescence in-situ hybridization for the identification of patients at risk for metastatic disease in uveal melanoma. Vaarwater J, van den Bosch T, Mensink HW, van Kempen C, Verdijk RM, Naus NC, Paridaens D, Brüggenwirth HT, Kiliç E, de Klein A. Melanoma Res; 2012 Feb 04; 22(1):30-7. PubMed ID: 22157614 [Abstract] [Full Text] [Related]
13. Whole-genome copy-number analysis identifies new leads for chromosomal aberrations involved in the oncogenesis and metastastic behavior of uveal melanomas. van Engen-van Grunsven AC, Baar MP, Pfundt R, Rijntjes J, Küsters-Vandevelde HV, Delbecq AL, Keunen JE, Klevering JB, Wesseling P, Blokx WA, Groenen PJ. Melanoma Res; 2015 Jun 04; 25(3):200-9. PubMed ID: 25756553 [Abstract] [Full Text] [Related]
14. Personalized Prognosis of Uveal Melanoma Based on Cytogenetic Profile in 1059 Patients over an 8-Year Period: The 2017 Harry S. Gradle Lecture. Shields CL, Say EAT, Hasanreisoglu M, Saktanasate J, Lawson BM, Landy JE, Badami AU, Sivalingam MD, Hauschild AJ, House RJ, Daitch ZE, Mashayekhi A, Shields JA, Ganguly A. Ophthalmology; 2017 Oct 04; 124(10):1523-1531. PubMed ID: 28495150 [Abstract] [Full Text] [Related]
15. Molecular cytogenetic analysis of archival uveal melanoma with known clinical outcome. Mensink HW, Kiliç E, Vaarwater J, Douben H, Paridaens D, de Klein A. Cancer Genet Cytogenet; 2008 Mar 04; 181(2):108-11. PubMed ID: 18295662 [Abstract] [Full Text] [Related]
16. Chromosome 3 analysis of uveal melanoma using fine-needle aspiration biopsy at the time of plaque radiotherapy in 140 consecutive cases: the Deborah Iverson, MD, Lectureship. Shields CL, Ganguly A, Materin MA, Teixeira L, Mashayekhi A, Swanson LA, Marr BP, Shields JA. Arch Ophthalmol; 2007 Aug 04; 125(8):1017-24. PubMed ID: 17698747 [Abstract] [Full Text] [Related]
17. Cytogenetics of iris melanomas: disparity with other uveal tract melanomas. Sisley K, Brand C, Parsons MA, Maltby E, Rees RC, Rennie IG. Cancer Genet Cytogenet; 1998 Mar 04; 101(2):128-33. PubMed ID: 9494614 [Abstract] [Full Text] [Related]